Barclays’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $191K | Buy |
48,773
+30,503
| +167% | +$119K | ﹤0.01% | 3565 |
|
|
2025
Q1 | $69K | Sell |
18,270
-9,456
| -34% | -$35.7K | ﹤0.01% | 3799 |
|
|
2024
Q4 | $151K | Buy |
+27,726
| New | +$151K | ﹤0.01% | 3635 |
|
|
2021
Q4 | – | Sell |
-4,616
| Closed | -$19K | – | 3357 |
|
|
2021
Q3 | $19K | Buy |
4,616
+3,208
| +228% | +$13.2K | ﹤0.01% | 3644 |
|
|
2021
Q2 | $6K | Sell |
1,408
-2,004
| -59% | -$8.54K | ﹤0.01% | 3944 |
|
|
2021
Q1 | $31K | Buy |
+3,412
| New | +$31K | ﹤0.01% | 3596 |
|